Marshall Wace
KRON

Marshall Wace’s Kronos Bio KRON Stock Holding History

Marshall Wace’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-126,309
Closed -$217K – 2464
2023
Q2 		$217K Sell
126,309
-61,892
-33% -$98.3K ﹤0.01% 2226
2023
Q1 		$275K Sell
188,201
-11,407
-6% -$21.9K ﹤0.01% 2326
2022
Q4 		$323K Sell
199,608
-41,291
-17% -$95K ﹤0.01% 2537
2022
Q3 		$807K Sell
240,899
-108,153
-31% -$488K ﹤0.01% 2511
2022
Q2 		$1.27M Buy
349,052
+272,983
+359% +$1.24M ﹤0.01% 2297
2022
Q1 		$550K Buy
+76,069
New +$649K ﹤0.01% 2732
2021
Q3 		– Sell
-48,616
Closed -$1.16M – 3242
2021
Q2 		$1.16M Buy
+48,616
New +$1.23M 0.01% 1736

Other funds holding KRON

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.65B AUM 16.42% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marshall Wace's KRON Position: Q3 2023 in Review

Marshall Wace sold out of Kronos Bio (KRON) in Q3 2023, closing a stake of 126,309 shares — an estimated $217K sold.

Marshall Wace first reported a position in KRON in Q2 2021 and held it in 7 quarters. The position peaked at $1.27M in Q2 2022. 63 funds tracked by Wall St. Rank hold KRON as of Q3 2023.

  • Marshall Wace reported no remaining Kronos Bio position as of Q3 2023 after selling out during the quarter.
  • Marshall Wace sold 126,309 Kronos Bio shares in Q3 2023, an estimated $217K.
  • Marshall Wace first reported a position in Kronos Bio in Q2 2021 and held it in 7 quarters.
  • Marshall Wace's Kronos Bio position peaked at $1.27M in Q2 2022.
  • 63 funds tracked by Wall St. Rank held Kronos Bio as of Q3 2023.

Based on Marshall Wace's 13F filing for Q3 2023, filed 14 Nov 2023.